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Abstract
Objective To investigate the effect of the CONSORT for Abstracts
guidelines, and different editorial policies used by five leading general
medical journals to implement the guidelines, on the reporting quality of
abstracts of randomised trials.
Design Interrupted time series analysis.
Sample We randomly selected up to 60 primary reports of randomised
trials per journal per year from five high impact, general medical journals
in 2006-09, if indexed in PubMed with an electronic abstract. We
excluded reports that did not include an electronic abstract, and any
secondary trial publications or economic analyses. We classified journals
in three categories: those not mentioning the guidelines in their
instructions to authors (JAMA and New England Journal of Medicine),
those referring to the guidelines in their instructions to authors but with
no specific policy to implement them (BMJ), and those referring to the
guidelines in their instructions to authors with an active policy to
implement them (Annals of Internal Medicine and Lancet). Two authors
extracted data independently using the CONSORT for Abstracts
checklist.
Main outcome Mean number of CONSORT items reported in selected
abstracts, among nine items reported in fewer than 50% of the abstracts
published across the five journals in 2006.
Results We assessed 955 reports of abstracts of randomised trials.
Journals with an active policy to enforce the guidelines showed an
immediate increase in the level of mean number of items reported
(increase of 1.50 items; P=0.0037). At 23 months after publication of
the guidelines, the mean number of items reported per abstract for the
primary outcome was 5.41 of nine items, a 53% increase compared with
the expected level estimated on the basis of pre-intervention trends. The
change in level or trend did not increase in journals with no policy to
enforce the guidelines (BMJ, JAMA, and New England Journal of
Medicine).
Conclusion Active implementation of the CONSORT for Abstracts
guidelines by journals can lead to improvements in the reporting of
abstracts of randomised trials.
Introduction
Clear, transparent, and sufficiently detailed abstracts of journal
articles reporting randomised trials are important, because
readers often base their initial assessments of a trial on the
content of the abstract. In some cases, health practitioners will
have access only to the abstract, and could, therefore, make
healthcare decisions based solely on the information in that
abstract.
1 As such, the journal abstract should be a clear and
accurate reflection of what is included in the journal article.
However, several studies have highlighted problems in the
accuracyandqualityofabstracts,includingalackofinformation
about the trial methodology and the robustness of the trial
results.
2 3 Studies comparing the accuracy of information
reported in a journal abstract with that reported in the text of
thefullpublicationhavefoundclaimsthatareinconsistentwith,
or missing from, the body of the full article.
4 5 This inadequate
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Research
RESEARCHreporting could seriously mislead a reader’s interpretation of
the trial findings.
6
In response to these limitations, an extension to the CONSORT
statement (CONsolidated Standards Of Reporting Trials) was
published in January 2008, providing a list of essential items to
include when reporting the main results of a randomised trial
in a journal or conference abstract.
7 8 However, the effect of the
CONSORT for Abstracts guidelines has not been widely
evaluated. In this study, we aimed to investigate the effect of
these guidelines, and journals’ editorial policy to implement
them, on the reporting quality of abstracts of randomised trials
published.
Methods
Design and sample
To assess the effect of publication of the CONSORT for
Abstracts guidelines, we planned a segmented regression of
interrupted time series analyses, a quasi-experimental design
methodfrequentlyusedandrecommendedtoevaluatetheeffect
of guidelines or other complex interventions.
9
We selected all primary reports of randomised trials indexed in
PubMed(publicationtype“RandomizedControlledTrial”)and
published in one of five high impact general medical journals
(theAnnalsofInternalMedicine,BMJ,Lancet,JAMA,andNew
England Journal of Medicine). We excluded reports that did
not include an electronic abstract, and any secondary trial
publications or economic analyses. Because the number of
randomised trials published by journals varies each year, we
selectedatrandom(www.random.org)asampleofupto60trial
reports per journal per year for inclusion in our final sample. If
fewer than 60 reports of randomised trials were obtained for a
journal in a particular year, we assessed all eligible reports.
Interventions
We aimed to assess the effect of the publication of the
CONSORT for Abstracts guidelines and the effect of different
editorialpoliciesusedtoimplementtheseguidelines.Therefore,
we checked each journal’s instructions to authors in January
2010 for any reference to the CONSORT for Abstracts
guidelines (for example, reference to a publication or link to
the relevant section of the CONSORT website). For those
journals that mentioned the guidelines in their instructions to
authors, we contacted the editor of that journal to ask when the
guidancewasadded,whetherthejournalenforcedtheguidelines,
and if so, how. We classified journals in three categories: those
not mentioning the CONSORT guidelines in their instructions
to authors (JAMA and the New England Journal of Medicine);
those referring to the guidelines in their instructions to authors,
butwithnospecificpolicytoimplementthem(BMJ);andthose
referring to the guidelines in their instructions to authors, with
a policy to implement them (Annals of Internal Medicine and
the Lancet). In the final journal group, we defined such an
implementation policy as having any action to enforce the
adherence to CONSORT—that is, an email was sent to authors
to revise the abstract according to the CONSORT for Abstracts
guidance at the revision stage of the manuscript, or changes
were made by the assistant editors of these journals towards the
end of the editorial process.
The study period
For the purpose of the study, we selected abstracts published
between January 2006 and December 2009. The CONSORT
forAbstractsguidelineswerepublishedintheLancet
8andPloS
Medicine
7 in January 2008 (26 and 22 January, respectively).
Shortly after publication (January 2008), the Annals of Internal
Medicine, Lancet, and BMJ added the guidelines to their
instructions to authors.
Overall, the study period had 48 monthly intervals: 25 before
the publication of the CONSORT for Abstracts guidelines
(January2008),threeduringatransitionperiodtoaccommodate
a gradual implementation (February 2008 to April 2008), and
20 after the intervention (we considered that the intervention
began in May 2008).
Outcomes
The primary outcome was a composite outcome. We decided a
priori only to focus on items that were reported in fewer than
50% of the abstracts across the five journals in 2006. By
focusing only on items that were poorly reported, we hoped to
seethegreatesteffectofimplementationoftheguidelines(box,
web table 1). Therefore, our primary outcome was the monthly
mean number of items reported per abstract on a 0 to 9 scale.
Foroursecondaryoutcome,weassesseditemsreportedinfewer
than20%ofabstractsacrossthefivejournalsin2006(box,web
table1).Consequently,thesecondaryoutcomewasthemonthly
mean number of items reported per abstract on a 0 to 5 scale.
Data extraction
For each included abstract, we checked to see whether items
included in the CONSORT for Abstracts guidelines were
adequately reported or not reported. Single data extraction was
carriedoutbytwoauthors(SHandIB).Abstractswereallocated
at random to the two assessors across the five journals and time
periods; thus, each assessor reviewed a similar number of
abstracts from each journal per year. However, both authors
first piloted the data extraction form to ensure consistency in
the extraction process. Any uncertainty regarding a particular
abstract was checked and resolved by discussion. It was not
possibletoblindassessorstothejournalbeingreviewed,because
abstracts for each journal had their own particular house style.
Data analysis
We plotted outcomes graphically over time (by month blocks)
from 2006 to 2009 (we excluded the three month transition
period from the statistical models but included it in the visual
presentationoffigures1⇓and2⇓.Thisallowedustoassess,for
theprimaryandsecondaryoutcomes,anyimprovementsbefore
and after the intervention. We fitted a time series segmented
linearregressionandestimatedmonthlyusetoevaluatechanges
afterthepublicationoftheCONSORTforAbstractsguidelines.
The model included terms to evaluate the following variables:
a constant term (for levels before the intervention at baseline),
atermforlineartrendsbeforetheintervention,termstoestimate
level and trend changes after the intervention, and a residual
term. Web appendix 1 provides more information about the
statistical model. The ordinary least square model assumes a
linear association between time (before and after intervention)
and the outcome. We used the Durbin-Watson test to check for
autocorrelation. If a Durbin-Watson test result was significant,
we corrected the model for autocorrelated errors. One key
assumption of ordinary regression analysis is that the errors are
independent of each other. To overcome this problem, we used
a stepwise autoregression method that initially fits a high order
model with many autoregressive lags and then sequentially
removes autoregressive parameters until all remaining
autoregressive parameters have significant t tests.
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RESEARCHBox: Study outcomes
Primary outcome: items reported in fewer than 50% of abstracts across five journals in 2006
Details of the trial design
Allocation sequence generation
Allocation concealment
Detailed blinding status (that is, who was blinded)
Number of participants randomised to each group
Number of participants analysed in each group
For the primary outcome, results for each group and its effect size
Harms data
Funding source
Secondary outcome: items reported in fewer than 20% of abstracts across five journals in 2006
Allocation sequence generation
Allocation concealment
Detailed blinding status (that is, who was blinded)
Number of participants analysed in each group
Funding source
The models (one per outcome) used to estimate within group
changes were built on each of the following samples: all
journals, journals not mentioning the CONSORT for Abstracts
guidelines in their instructions to authors, journals referring to
the guidelines in their instructions to authors but with no policy
to implement them, and journals referring to the guidelines in
their instructions to authors with a policy to implement them.
Finally,weaddedadummygroupvariabletoindicateanactive
or inactive editorial policy and bivariate interaction terms (that
is,agroupbypre-interventiontrend,agroupbychangeinlevel,
and a group by change in trend) to the initial models (one per
outcome),totestfordifferencesbetweenjournalswithanactive
policyforimplementation(AnnalsofInternalMedicine,Lancet)
and those with no active policy (BMJ, JAMA, New England
JournalofMedicine).WeusedSASstatisticalsoftware(release
9.2, SAS Institute) for the statistical analyses, and considered
P<0.05 as significant.
Results
Weincluded955reportsofabstractsofrandomisedtrialsinour
final sample and included trials from a wide variety of clinical
specialties.
All journals
Figure 1 and web table 2 detail the change in the mean number
of items reported per abstract for the primary and secondary
outcomes before and after the introduction of the CONSORT
forAbstractsguidelinesforalljournals.Overall,fortheprimary
outcome, publication of the CONSORT guidelines did not lead
toasignificantincreaseinthelevelofthemeannumberofitems
reported (increase of 0.3035 of nine items, P=0.16) or the trend
(increaseof0.0193itemspermonth,P=0.21).Forthesecondary
outcome, we saw a significant increase in the level of the mean
number of items reported after the implementation of the
CONSORT guidelines (increase of 0.3882 of five items,
P=0.0072) and in trends (increase of 0.0288 items per month,
P=0.0025). Web table 3 provides the individual data per
checklist item, per journal per year.
Effect of the journal policy
WefirstfocusedonjournalsnotmentioningtheCONSORTfor
Abstractsguidelinesintheirinstructionstoauthors(JAMA,New
England Journal of Medicine) and journals referring to the
guidelines in their instructions to authors but with no policy of
enforcementofthem(BMJ).Weobservednosignificantincrease
in the level change or trend change for the primary and
secondary outcomes (fig 2, web table 2).
However, when focusing on journals with an active policy to
enforcetheCONSORTguidelines(AnnalsofInternalMedicine,
Lancet),thepublicationandeditorialpolicyledtoanimmediate
increase in the level of mean number of items reported but no
further improvement in trend for the primary outcome (fig 2,
web table 2). At baseline, in January 2006, the mean number
of items reported per abstract was 1.52 of nine items, which
increased to 2.56 nine items during the 25 months before the
intervention. Implementation of the CONSORT guidelines led
to an immediate significant increase of 1.50 immediately after
theintervention(P=0.0037).However,thetrenddidnotchange
(increaseof0.0193itemspermonth,P=0.6).InDecember2009,
23 months after the publication of the guidelines, the mean
number of items reported per abstract for the primary outcome
in the Annals of Internal Medicine and the Lancet was 5.41
items, which represented a 53% increase compared with the
expectedlevelestimatedonthebasisofpre-interventiontrends.
Web appendix 2 shows data for each of the nine items, per
journal, over time.
For the primary outcome, we used a model to compare journals
that had an active policy with those that did not have an active
policy.Themodelshowedasignificantdifferenceinthechange
in level (that is, relative to the inactive policy group). The
change in level immediately after implementation of the
CONSORT for Abstracts guidelines increased significantly
(increaseof1.90items,P=0.0006forinteractiontest).However,
we saw a non-significant difference in trend change (increase
of 0.0316 items per month relative to the inactive policy group,
P=0.3915 for interaction test).
For the secondary outcome, when focusing only on the Annals
of Internal Medicine and Lancet at baseline in January 2006,
themeannumberofitemsreportedperabstractwas0.18offive
items(fig2,webtable2).Thislevelhadincreasedto0.42items
during the 25 months before the intervention. Implementation
of the CONSORT for Abstracts guidelines led to a significant
increase in the mean number of items reported per abstract
immediately after the intervention (increase of 1.03 items,
P=0.0035)andasignificantchangeintrend(increaseof0.0613
items per month, P=0.0154). In December 2009, 23 months
after publication of the guidelines, the secondary outcome
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RESEARCHreached 2.91 points in the Annals of Internal Medicine and
Lancet,a4.5-fold(350%)increasecomparedwiththeexpected
level estimated on the basis of pre-intervention trends.
Themodelusedforcomparingjournalsthathadanactivepolicy
with those that did not have active policy for the secondary
outcome showed a significant difference between groups in the
change in level (relative to the inactive policy group, increase
of1.24items,P<0.0001forinteractiontest)andchangeintrend
afterimplementationoftheCONSORTforAbstractsguidelines
(increase of 0.0761 items per month, P<0.0001 for interaction
test).
Discussion
This study evaluated the effect of journals’ editorial policy to
implement the CONSORT extension for abstracts guidelines
on the reporting quality of abstracts of randomised trials
published in five high impact, general medical journals. After
publication of the guidelines in January 2008, we identified a
significant increase in the reporting of key items in the two
journals(AnnalsofInternalMedicine,andLancet)thatendorsed
the guidelines in their instructions to authors and that had an
active editorial policy to implement them. By comparison, we
observednosignificantdifferenceintheonejournal(BMJ)that
endorsed the guidelines but did not have an active
implementation strategy, and in the two journals (JAMA, New
EnglandJournalofMedicine)thatdidnotendorsetheguidelines
in their instructions to authors.
Comparison with other studies
Several studies have assessed the quality of published reports
ofabstractsofrandomisedtrials.
2-4 10-12Thesestudiesallhighlight
problems in the accuracy and quality of abstract reporting,
particularly a lack of information about the trial methodology
and the robustness of its results.
2 11 No studies have evaluated
the effect of the CONSORT for Abstracts guidelines over time.
Ourstudyusedasegmentedregressionofinterruptedtimeseries
analyses, a quasi-experimental design method to evaluate the
effect of the guidelines.
13 In such designs, multiple
measurements are taken before and after an intervention are
applied. This design is effective if a fairly large number of
measurements for the outcome of interest are available and a
segmentedregressioncanbeusedtoanalysethedata.Segmented
regression can identify both sudden change due to an
intervention, as well as more gradual changes over time.
For clinical practice guidelines, reporting guidelines aim to
improve knowledge (authors are aware of the guidelines),
attitudes (authors agree and accept the guidelines as a new
standard), behaviour (authors change practice patterns to
conform with the guidelines), and outcomes (the guidelines
improve reporting).
14 For this purpose, a strategy of
dissemination and implementation of the guidelines is
necessary.
15
The CONSORT for Abstract guidelines were disseminated
through its publication in two general medical journals with
high impact factors.
7 8 In October 2008, the International
Committee of Medical Journal Editors also recommended that
“articles on clinical trials should contain abstracts that include
the items that the CONSORT group has identified as essential
(www.consort-statement.org)”(www.icmje.org).Furthermore,
since publication, the guidelines have also been incorporated
into the recently revised main CONSORT statement in March
2010.
16 17 Dissemination was also enforced by some journal
editors referring to the CONSORT for Abstracts guidelines in
their instructions to authors.
However, our results show that the guidelines improved
reportingonlywhenactivelyimplementedbyaspecificeditorial
policy. This policy implied a relatively simple intervention
consisting of an email sent to authors to revise the abstract
according to CONSORT guidance at the revision stage of the
manuscriptand,insomeinstances,furtherchangesmadebythe
journals’ assistant editors at the end of the editorial process.
Our results accord with those of systematic reviews showing
that,invariousfields,passivedisseminationofinformationwas
generally ineffective and that the use of specific strategies to
implement research based recommendations seems to be
necessary to ensure that practices change.
18
Limitations
Our study has several limitations. We based our study on
abstracts of randomised trials published in five high impact,
general medical journals, all of which have considerable
resourcestosupporttheirwork.Werecognisethattheresources
and procedures available for these journals might not be the
same for all journals; therefore, it is not possible to say that
what works in these journals is applicable in other smaller, less
well resourced journals. Furthermore, the overall reporting
quality of abstracts published in these five journals might be
higher than in other less well known journals, which was
certainly the case when comparing the reporting of CONSORT
items in general journals with reporting in specialty journals.
19
Ourprimaryoutcomewasacompositeoutcome,whichfocused
on the nine CONSORT items reported in fewer than 50% of
abstracts in 2006. This composite outcome assumed that each
of the nine items were equally important, which might not
always be the case, depending on the perspective of the reader.
However, by focusing only on items that were poorly reported,
we hoped to see the greatest effect of implementation of the
guidelines.
Finally,weallowedathreemonthtransitionperiodinourstudy,
duringwhichwecouldimplementandmeasuretheeffectofthe
CONSORT for Abstracts guidelines. This transition period
might have been longer for some articles, since they can take
longer than three months to pass through the editorial process.
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RESEARCHFigures
Fig 1 Change in outcomes from January 2006 to December 2009, before and after the introduction of the CONSORT for
Abstracts guidelines implemented in January 2008 for all journals. Circles=actual values; straight lines=regression lines
traced out by the structural predicted values; jagged lines=full model prediction values formed from both the structural and
autoregressive parts of the model; vertical lines=transition phase (February to April 2008)
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RESEARCHFig 2 Change in outcomes from January 2006 to December 2009, before and after introduction of the CONSORT for
Abstracts guidelines implemented in January 2008 for each journal category. Circles=actual values; straight lines=regression
lines traced out by the structural predicted values; vertical lines=transition phase (February to April 2008)
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